Current Multimodality Treatments against Brain Metastases from Renal Cell Carcinoma

SIMPLE SUMMARY: Brain metastasis (BM) is generally one of poor prognostic factors in patients with advanced renal cell carcinoma. However, because of longer control of extra-cranial disease by the recent introduction of molecular target therapy and immune checkpoint inhibitor, the incidence of BM ha...

Descripción completa

Detalles Bibliográficos
Autor principal: Matsui, Yoshiyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7600559/
https://www.ncbi.nlm.nih.gov/pubmed/33036276
http://dx.doi.org/10.3390/cancers12102875

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7600559/
https://www.ncbi.nlm.nih.gov/pubmed/33036276
http://dx.doi.org/10.3390/cancers12102875

Ejemplares similares